M. Inukai

发表

A novel assay of bacterial peptidoglycan synthesis for natural product screening

R. Murakami, Yasunori Muramatsu, E. Minami, 2009, The Journal of Antibiotics.

Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli

R. Southgate, T. Bugg, M. Inukai, 1996, Antimicrobial agents and chemotherapy.

Pleofungins, Novel Inositol Phosphorylceramide Synthase Inhibitors, from Phoma sp. SANK 13899. Part 1. Taxonomy, Fermentation, Isolation, and Biological Activities.

Yasuhiro Suzuki, Y. Kawamura, T. Takatsu, 2007 .

Pleofungins, Novel Inositol Phosphorylceramide Synthase Inhibitors, from Phoma sp. SANK 13899

Yasuhiro Suzuki, Y. Kawamura, T. Takatsu, 2007, The Journal of Antibiotics.

Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. I. Taxonomy, fermentation and biological properties.

A. Satoh, I. Kaneko, Y. Sakaida, 1993, The Journal of antibiotics.

Structure-activity relationships of globomycin analogues as antibiotics.

H. Kogen, K. Yasuda, S. Miyakoshi, 2004, Bioorganic & medicinal chemistry.

Synthesis and antimicrobial activity of novel globomycin analogues.

H. Kogen, K. Yasuda, S. Miyakoshi, 2003, Bioorganic & medicinal chemistry letters.

Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis

M. Inukai, F. Isono, 1991, Antimicrobial Agents and Chemotherapy.

F-10748 A1, A2, B1, B2, C1, C2, D1 and D2, novel papulacandins.

T. Hosoya, S. Miyakoshi, M. Inukai, 2002, The Journal of antibiotics.

Deletion of OSH3 gene confers resistance against ISP-1 in Saccharomyces cerevisiae.

M. Inukai, F. Isono, T. Yano, 2004, Biochemical and biophysical research communications.

Association of the prolipoprotein accumulated in the presence of globomycin with the outer membrane of Escherichia coli.

M. Inouye, M. Inukai, 2005, European journal of biochemistry.

Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: physico-chemical properties and structure elucidation.

S. Miyakoshi, M. Inukai, K. Hamano, 2003, The Journal of antibiotics.

Liposidomycin B inhibits in vitro formation of polyprenyl (pyro)phosphate N-acetylglucosamine, an intermediate in glycoconjugate biosynthesis.

H. Osada, A. Takatsuki, M. Muroi, 1997, The Journal of antibiotics.

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

Y. Sakaida, M. Inukai, F. Isono, 1989, The Journal of antibiotics.

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation.

M. Inukai, F. Isono, H. Kuwano, 1989, The Journal of antibiotics.

Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity.

Y. Kurihara, S. Miyakoshi, M. Inukai, 2000, The Journal of antibiotics.

Preferential selection of deletion mutations of the outer membrane lipoprotein gene of Escherichia coli by globomycin

M. Inouye, K. Nakamura, L. Zwiebel, 1981, Journal of bacteriology.

Mechanism of action of globomycin.

M. Inukai, M. Takeuchi, M. Arai, 1978, The Journal of antibiotics.

Effects of inserting eight amino acid residues into the major lipoprotein on its assembly in the outer membrane of Escherichia coli

M. Inouye, M. Inukai, G. Vlasuk, 1983, Journal of bacteriology.

A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.

T. Ohnuki, Yasunori Muramatsu, T. Takatsu, 2004, The Journal of antibiotics.

Structure–function studies on nucleoside antibiotic mureidomycin A: synthesis of 5′-functionalised uridine models

T. Bugg, M. Inukai, S. Harrison, 1999 .

Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins

A. Takatsuki, M. Inukai, F. Isono, 1993, Antimicrobial Agents and Chemotherapy.

A-102395, a New Inhibitor of Bacterial Translocase I, Produced by Amycolatopsis sp. SANK 60206

R. Murakami, Yasunori Muramatsu, T. Takatsu, 2007, The Journal of Antibiotics.

HELVECARDINS A AND B, NOVEL GLYCOPEPTIDE ANTIBIOTICS

M. Inukai, T. Kinoshita, Takemichi Nakamura, 1991 .

Helvecardins A and B, novel glycopeptide antibiotics. I. Taxonomy, fermentation, isolation and physico-chemical properties.

M. Inukai, T. Okazaki, R. Enokita, 1991, The Journal of antibiotics.

Malioxamycin, a new antibiotic with spheroplast-forming activity. I. Producing organism, fermentation, isolation and characterization.

M. Inukai, S. Takahashi, S. Iwado, 1980, The Journal of antibiotics.

Mureidomycins E and F, minor components of mureidomycins.

Y. Sakaida, M. Inukai, F. Isono, 1993, The Journal of antibiotics.

Galacardins A and B, new glycopeptide antibiotics.

H. Haruyama, Y. Sakaida, M. Inukai, 1992, The Journal of antibiotics.

Fosfonochlorin, a new antibiotic with spheroplast forming activity.

M. Inukai, T. Ogita, M. Nakajima, 1989, The Journal of antibiotics.

Globomycin, a new peptide antibiotic with spheroplast-forming activity. III. Structural determination of globomycin.

M. Inukai, T. Kinoshita, A. Terahara, 1978, The Journal of antibiotics.

Helvecardins A and B, novel glycopeptide antibiotics. III. Biological properties.

M. Inukai, M. Takeuchi, T. Katayama, 1991, Journal of antibiotics (Tokyo. 1968).

Helvecardins A and B, novel glycopeptide antibiotics. II. Structural elucidation.

M. Inukai, T. Kinoshita, S. Takahashi, 1991, The Journal of antibiotics.

Temperature-sensitive processing of outer membrane lipoprotein in an Escherichia coli mutant

M. Inouye, H. Yamagata, M. Inukai, 1982, Journal of bacteriology.

Globomycin sensitivity of Escherichia coli and Salmonella typhimurium: effects of mutations affecting structures of murein lipoprotein

W. Philbrick, Y. Hirota, M. Inukai, 1981, Journal of bacteriology.

Globomycin, a new peptide antibiotic with spheroplast-forming activity. II. Isolation and physico-chemical and biological characterization.

M. Inukai, M. Nakajima, T. Haneishi, 1978, The Journal of antibiotics.

Dual functions of the signal peptide in protein transfer across the membrane

Masatoshi Inukai, M. Inouye, M. Inukai, 1985, Cell.

Globomycin, a new peptide antibiotic with spheroplast-forming activity. I. Taxonomy of producing organisms and fermentation.

M. Inukai, A. Torikata, S. Iwado, 1978, The Journal of antibiotics.

Apolipoprotein, an intermediate in the processing of the major lipoprotein of the Escherichia coli outer membrane.

M. Inouye, J. Ghrayeb, K. Nakamura, 1984, Journal of Biological Chemistry.

Existence of the bound form of prolipoprotein in Escherichia coli B cells treated with globomycin

M. Inukai, M. Takeuchi, M. Arai, 1979, Journal of bacteriology.

Studies on Novel Bacterial Translocase I Inhibitors, A-500359s

Yasunori Muramatsu, Y. Sakaida, S. Miyakoshi, 2006, The Journal of Antibiotics.

Augmentation of Host Resistance against Bacterial Infection by Treatment with Leustroducsin B, a New CSF Inducer

H. Maeda, M. Inukai, T. Kohama, 1994, Microbiology and immunology.

Slow Binding Inhibition of Phospho-N-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by Mureidomycin A (*)

R. Southgate, T. Bugg, M. Inukai, 1996, The Journal of Biological Chemistry.

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. III. Biological properties.

M. Inukai, F. Isono, T. Haneishi, 1989, The Journal of antibiotics.

A new carbapenam No. 17927 D substance.

N. Serizawa, M. Inukai, H. Kuwano, 1983, Journal of antibiotics (Tokyo. 1968).

Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.

T. Ohnuki, Yasunori Muramatsu, T. Takatsu, 2003, The Journal of antibiotics.

A-94964, a Novel Inhibitor of Bacterial Translocase I, Produced by Streptomyces sp. SANK 60404

R. Murakami, Yasunori Muramatsu, T. Takatsu, 2008, The Journal of Antibiotics.

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds.

Yasunori Muramatsu, T. Takatsu, S. Miyakoshi, 2003, Bioorganic & medicinal chemistry letters.

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.

Yasunori Muramatsu, T. Takatsu, S. Miyakoshi, 2003, Bioorganic & medicinal chemistry letters.

Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

Yasunori Muramatsu, M. Inukai, M. Ishii, 2003, The Journal of antibiotics.

Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2.

T. Ohnuki, Yasunori Muramatsu, T. Takatsu, 2003, The Journal of antibiotics.

Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.

T. Ohnuki, Yasunori Muramatsu, T. Takatsu, 2003 .

Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins

M. Inukai, F. Isono, K. Kodama, 1992, Antimicrobial Agents and Chemotherapy.